Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Join this 40-minute webinar exploring the successful decentralization of MSK-ACCESS® on the SOPHiA DDM™ Platform, presented by Dr. Florian Klemm and Leah Thompson from Tennessee Oncology. Discover how Memorial Sloan Kettering Cancer Center's collaboration with SOPHiA GENETICS has overcome key decentralization challenges while maintaining high analytical concordance with single-site testing. Learn about findings from internal verification studies and real-world data from seven early adopter sites that demonstrate the platform's effectiveness in precision oncology applications. Examine the complexities of decentralizing liquid biopsy solutions, including analytical accuracy challenges, wet-lab standardization requirements, and noise reduction strategies. Gain insights into performance validation results showing high concordance between decentralized and centralized versions of MSK-ACCESS®, supported by advanced analytics and standardized processes. Explore real-world implementation experiences through Tennessee Oncology's perspective on assay verification, workflow efficiency, and routine laboratory integration. Understand how this decentralized approach streamlines laboratory workflows, ensures reliable data quality, and simplifies implementation processes while expanding access to high-quality genomic testing. Discover the broader impact on precision oncology through community-driven insights that continuously improve variant calling algorithms and foster collaborative advancement in cancer diagnostics.
